LongevityRecoveryEarly research

Thymosin Beta-4 Sulfoxide

Thymosin Beta-4 Sulfoxide

AI explanation

Thymosin Beta-4 Sulfoxide Explained

Think of thymosin beta-4 sulfoxide as your body's anti-inflammatory bouncer. It's a small protein fragment that your body naturally produces, and people are interested in it because it seems to calm down overactive immune responses—the kind that cause problems in inflammatory and autoimmune conditions.

Here's what happens when you have this peptide working in your system: your immune cells, particularly the aggressive ones called macrophages and neutrophils, are like security guards that sometimes overreact and cause collateral damage. This peptide tells those guards to stand down and move away from inflamed areas. It's doing this by working through specific pathways in your cells—essentially flipping switches that reduce inflammatory signals your body sends out.

What makes this version special is a tiny chemical change: one part of the molecule has been slightly oxidized, which sounds like degradation but actually creates something with entirely different powers. Unlike its parent compound which helps repair tissue by rearranging your cell's structural proteins, this oxidized version focuses purely on the immune side. It activates survival pathways in stressed cells and blocks the production of inflammatory messengers. It's like the difference between a handyman fixing damage versus a negotiator preventing conflict in the first place—same tool family, completely different job.

Dosage Information

Typical Dose

1-2 mg

Frequency

Twice weekly

Anytime

Administration

Subcutaneous injection

Half-Life

~2 hours

estimated

Notes

Often compared and contrasted with TB-500 (Thymosin Beta-4). Some protocols alternate between the two. Limited clinical human data available.

Why this matters

Similar to TB-500; rapid clearance supports frequent dosing protocols.

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

Sign in to save your reconstitution settings for this peptide

Draw to the

40

unit mark

020406080100

Draw 40 units for your 1000mcg dose of Thymosin Beta-4 Sulfoxide

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does Thymosin Beta-4 Sulfoxide sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.13

Clinical trials
0.0035%
Literature
0.1330%
Community
0.0020%
Completeness
0.6315%

Potential Side Effects

Injection site reactions (uncommon)Fatigue (rare)Limited human safety data
Pep Talk

Thymosin Beta-4 Sulfoxide discussions

Quick Facts

Administration
Subcutaneous injection
Typical Dose
1-2 mg
Frequency
Twice weekly
References
0 curated + 6 from PubMed
Evidence Score
0.1 / 100

Frequently Asked Questions about Thymosin Beta-4 Sulfoxide

What is Thymosin Beta-4 Sulfoxide?

Thymosin Beta-4 Sulfoxide is the naturally oxidized form of Thymosin Beta-4 (TB-500) in which the methionine residue at position 6 is converted to methionine sulfoxide. Rather than simply being a degradation product TB4-SO has demonstrated distinct and potent anti-inflammatory biological activities that differ from and complement those of the parent TB-500 molecule. It has attracted significant interest in inflammatory and autoimmune conditions where its specific immunomodulatory properties may be therapeutically advantageous over the parent compound.

How does Thymosin Beta-4 Sulfoxide work?

While TB-500 acts primarily through actin binding to promote tissue repair and angiogenesis TB4-SO acts preferentially as an anti-inflammatory agent. It inhibits the migration and activation of inflammatory immune cells particularly macrophages and neutrophils to sites of inflammation. TB4-SO activates the NINJ1 pathway involved in cell survival under inflammatory stress and modulates NF-κB signaling to reduce pro-inflammatory cytokine production. Importantly TB4-SO does not bind actin with the same affinity as TB-500 suggesting its beneficial effects are mediated through entirely different molecular targets. The oxidation of methionine appears to shift the peptide's activity from tissue repair toward immune modulation making TB4-SO a potentially more targeted option for conditions where excessive inflammation rather than tissue damage is the primary concern.

What is the recommended dosage for Thymosin Beta-4 Sulfoxide?

The typical dose is 1-2 mg. Twice weekly. Administration: Subcutaneous injection. Often compared and contrasted with TB-500 (Thymosin Beta-4). Some protocols alternate between the two. Limited clinical human data available.

What are the side effects of Thymosin Beta-4 Sulfoxide?

Injection site reactions (uncommon). Fatigue (rare). Limited human safety data

Questions reflect common community inquiries. This is not medical advice.